Track topics on Twitter Track topics that are important to you
The new version of belimumab can spare patients with systemic lupus erythematosus the need to have an intravenous infusion of the drug at a hospital or clinic. International Approvals
Belimumab is now approved in Japan for the treatment of adults with active, autoantibody-positive systemic lupus erythematosus who do not respond adequately to existing therapies. International Appr...
Ultrasonography of the major salivary glands may have a role in the diagnostic evaluation of patients with clinically suspected primary Sjogren's syndrome, researchers from the Netherlands report. R...
DelveInsight's Sjogren's Syndrome Market Insights, Epidemiology and Market Forecast2023 Reports provides an overview of the disease and global market trends of the Sjogren's Syndrome for the seven ma...
MADRID — Belimumab plus standard therapy was safe and effective over 10 years in patients with lupus, according to findings presented at the EULAR Annual Congress. “In lupus, the underlying diseas...
Sjögren’s is a chronic autoimmune disease characterized by dry mouth and eyes, fatigue, and musculoskeletal pain resulting from the attack of the moisture-producing glands by the body’s own white...
Sjögren’s syndrome is an autoimmune disease that affects over 2 million Americans, primarily over the age of 40. One of the major outcomes of Sjögren's syndrome is xerostomia (dry mouth) that is ...
Objective Intravenous belimumab 10 mg/kg is approved as an add-on therapy in patients with active, autoantibody-positive systemic lupus erythematosus. This study aimed to assess the impact of belimu...
To investigate whether Sjogren's syndrome would have an influence on the development of Parkinson's disease.
To report spectral domain optical coherence tomography and fundus autofluorescence documentation of late stage macular findings associated with Sjogren-Larsson Syndrome in three adult siblings.
Intravenous belimumab 10 mg/kg every 4 weeks is indicated in patients with active, autoantibody-positive systemic lupus erythematosus receiving standard systemic lupus erythematosus care. Subcutaneo...
Hypophosphatemic osteomalacia (HO) is a metabolic bone disease, exhibiting different etiologies such as genetic mutation, tumor induction, dysimmunity, or renal disease. Sjogren's syndrome (SS) is a c...